CN105168149B - 兽用清开灵颗粒剂的制备方法 - Google Patents
兽用清开灵颗粒剂的制备方法 Download PDFInfo
- Publication number
- CN105168149B CN105168149B CN201510644410.4A CN201510644410A CN105168149B CN 105168149 B CN105168149 B CN 105168149B CN 201510644410 A CN201510644410 A CN 201510644410A CN 105168149 B CN105168149 B CN 105168149B
- Authority
- CN
- China
- Prior art keywords
- preparation
- extract
- cholic acid
- hydrolyzate
- qingkailing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000008187 granular material Substances 0.000 title claims abstract description 31
- 239000008923 Qingkailing Substances 0.000 title claims abstract description 30
- 238000002360 preparation method Methods 0.000 title claims abstract description 26
- 239000003795 chemical substances by application Substances 0.000 title claims abstract description 24
- 241001465754 Metazoa Species 0.000 title claims abstract description 16
- 239000000284 extract Substances 0.000 claims abstract description 25
- BHQCQFFYRZLCQQ-UHFFFAOYSA-N (3alpha,5alpha,7alpha,12alpha)-3,7,12-trihydroxy-cholan-24-oic acid Natural products OC1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)C(O)C2 BHQCQFFYRZLCQQ-UHFFFAOYSA-N 0.000 claims abstract description 23
- 239000004380 Cholic acid Substances 0.000 claims abstract description 23
- BHQCQFFYRZLCQQ-OELDTZBJSA-N cholic acid Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 BHQCQFFYRZLCQQ-OELDTZBJSA-N 0.000 claims abstract description 23
- 235000019416 cholic acid Nutrition 0.000 claims abstract description 23
- 229960002471 cholic acid Drugs 0.000 claims abstract description 23
- KXGVEGMKQFWNSR-UHFFFAOYSA-N deoxycholic acid Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)C(O)C2 KXGVEGMKQFWNSR-UHFFFAOYSA-N 0.000 claims abstract description 23
- 241000205585 Aquilegia canadensis Species 0.000 claims abstract description 15
- 244000111489 Gardenia augusta Species 0.000 claims abstract description 15
- 235000018958 Gardenia augusta Nutrition 0.000 claims abstract description 15
- 239000010231 banlangen Substances 0.000 claims abstract description 15
- 229920000858 Cyclodextrin Polymers 0.000 claims abstract description 14
- XDQITMCFPPPMBC-TUANDBMESA-N scutelloside Natural products OC[C@H]1O[C@@H](O[C@@H]2O[C@@H]3C[C@H]4[C@H](O)[C@@H](O)[C@@](O)(CO3)[C@@H]24)[C@H](O)[C@@H](O)[C@@H]1O XDQITMCFPPPMBC-TUANDBMESA-N 0.000 claims abstract description 14
- 239000007788 liquid Substances 0.000 claims abstract description 12
- 239000000843 powder Substances 0.000 claims abstract description 12
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims abstract description 11
- 229930006000 Sucrose Natural products 0.000 claims abstract description 11
- 239000005720 sucrose Substances 0.000 claims abstract description 11
- 239000006286 aqueous extract Substances 0.000 claims abstract description 10
- DGABKXLVXPYZII-SIBKNCMHSA-N hyodeoxycholic acid Chemical compound C([C@H]1[C@@H](O)C2)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)CC1 DGABKXLVXPYZII-SIBKNCMHSA-N 0.000 claims abstract description 10
- 239000000463 material Substances 0.000 claims abstract description 10
- 239000011122 softwood Substances 0.000 claims abstract description 7
- 238000009777 vacuum freeze-drying Methods 0.000 claims abstract description 5
- 238000005469 granulation Methods 0.000 claims abstract description 4
- 230000003179 granulation Effects 0.000 claims abstract description 4
- 239000011812 mixed powder Substances 0.000 claims abstract description 4
- WHGYBXFWUBPSRW-FOUAGVGXSA-N beta-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FOUAGVGXSA-N 0.000 claims description 15
- 229960004853 betadex Drugs 0.000 claims description 15
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 10
- 239000001116 FEMA 4028 Substances 0.000 claims description 10
- 235000011175 beta-cyclodextrine Nutrition 0.000 claims description 10
- 150000001875 compounds Chemical class 0.000 claims description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 10
- 239000000706 filtrate Substances 0.000 claims description 7
- 238000000605 extraction Methods 0.000 claims description 6
- 238000002156 mixing Methods 0.000 claims description 6
- 241000217407 Margaritifera Species 0.000 claims description 5
- 238000000227 grinding Methods 0.000 claims description 5
- 239000002245 particle Substances 0.000 claims description 5
- 238000004064 recycling Methods 0.000 claims description 5
- 239000012141 concentrate Substances 0.000 claims description 3
- 239000002994 raw material Substances 0.000 claims description 3
- 230000008719 thickening Effects 0.000 claims description 3
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims description 2
- 229920002472 Starch Polymers 0.000 claims description 2
- 238000001035 drying Methods 0.000 claims description 2
- 238000001914 filtration Methods 0.000 claims description 2
- 239000010419 fine particle Substances 0.000 claims description 2
- 239000008101 lactose Substances 0.000 claims description 2
- 238000002791 soaking Methods 0.000 claims description 2
- 239000008107 starch Substances 0.000 claims description 2
- 235000019698 starch Nutrition 0.000 claims description 2
- 238000007710 freezing Methods 0.000 claims 1
- 230000008014 freezing Effects 0.000 claims 1
- 238000004806 packaging method and process Methods 0.000 claims 1
- 239000008188 pellet Substances 0.000 claims 1
- 238000003756 stirring Methods 0.000 claims 1
- 239000003814 drug Substances 0.000 abstract description 11
- 238000004519 manufacturing process Methods 0.000 abstract description 10
- 239000004480 active ingredient Substances 0.000 abstract description 9
- 206010037660 Pyrexia Diseases 0.000 abstract description 7
- 229940079593 drug Drugs 0.000 abstract description 6
- 230000000857 drug effect Effects 0.000 abstract description 6
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 abstract description 4
- 239000003292 glue Substances 0.000 abstract description 2
- 239000007779 soft material Substances 0.000 abstract description 2
- 238000000034 method Methods 0.000 description 6
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 235000019441 ethanol Nutrition 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 230000000694 effects Effects 0.000 description 2
- 238000007873 sieving Methods 0.000 description 2
- UYVVLXVBEQAATF-UHFFFAOYSA-N 4-(1,3,7,12-tetrahydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl)pentanoic acid Chemical compound OC1CC2CC(O)CC(O)C2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)C(O)C2 UYVVLXVBEQAATF-UHFFFAOYSA-N 0.000 description 1
- 206010010071 Coma Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 206010019468 Hemiplegia Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 206010061245 Internal injury Diseases 0.000 description 1
- SMEROWZSTRWXGI-UHFFFAOYSA-N Lithocholsaeure Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)CC2 SMEROWZSTRWXGI-UHFFFAOYSA-N 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 230000002567 autonomic effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 239000007938 effervescent tablet Substances 0.000 description 1
- 208000021760 high fever Diseases 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- SMEROWZSTRWXGI-HVATVPOCSA-N lithocholic acid Chemical compound C([C@H]1CC2)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)CC1 SMEROWZSTRWXGI-HVATVPOCSA-N 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 239000009112 niuhuang Substances 0.000 description 1
- 229940100688 oral solution Drugs 0.000 description 1
- 238000000643 oven drying Methods 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 239000007901 soft capsule Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
Abstract
Description
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510644410.4A CN105168149B (zh) | 2015-09-30 | 2015-09-30 | 兽用清开灵颗粒剂的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510644410.4A CN105168149B (zh) | 2015-09-30 | 2015-09-30 | 兽用清开灵颗粒剂的制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN105168149A CN105168149A (zh) | 2015-12-23 |
CN105168149B true CN105168149B (zh) | 2018-07-31 |
Family
ID=54890927
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510644410.4A Active CN105168149B (zh) | 2015-09-30 | 2015-09-30 | 兽用清开灵颗粒剂的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105168149B (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107913317A (zh) * | 2017-11-28 | 2018-04-17 | 广州白云山明兴制药有限公司 | 一种中药颗粒的制备方法 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1288724A (zh) * | 1999-09-17 | 2001-03-28 | 中外合资哈尔滨一洲制药有限公司 | 清开灵颗粒制备工艺 |
-
2015
- 2015-09-30 CN CN201510644410.4A patent/CN105168149B/zh active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1288724A (zh) * | 1999-09-17 | 2001-03-28 | 中外合资哈尔滨一洲制药有限公司 | 清开灵颗粒制备工艺 |
Non-Patent Citations (2)
Title |
---|
一例猪高热综合征的处理体会;周祎 等;《中国畜牧兽医报》;20120805;第1页 * |
防治猪高热 以不变应万变;赵瑞丽 等;《农民日报》;20120526;第1页 * |
Also Published As
Publication number | Publication date |
---|---|
CN105168149A (zh) | 2015-12-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN108185258A (zh) | 一种人参黄精固体饮料及其制备方法 | |
CN104739777B (zh) | 一种单味中药粉末的制备方法 | |
CN107320487B (zh) | 一种甘氨酸亚铁补铁制剂及其制备方法 | |
CN101091727B (zh) | 一种灵芝破壁孢子粉胶囊的制备方法 | |
CN103223104B (zh) | 一种治疗糖尿病的中药组合物及其制备方法 | |
CN107375443B (zh) | 一种补肺活血软胶囊及其制备方法 | |
CN105168149B (zh) | 兽用清开灵颗粒剂的制备方法 | |
CN1813979A (zh) | 二十六味通经胶囊 | |
CN101084952A (zh) | 一种刺五加皂苷提取物的制备方法 | |
CN102000172A (zh) | 一种防治慢性过敏性鼻炎的口服液、颗粒和散 | |
CN107929512B (zh) | 一种采用超高压提取制备龙牡壮骨颗粒的方法 | |
CN109874960B (zh) | 一种蜂花粉花粉晶的制备工艺 | |
CN105996034A (zh) | 一种抹茶味亚麻籽降胆固醇当归陈皮咀嚼片及其制备方法 | |
CN102266479A (zh) | 川贝雪梨颗粒及其制备方法 | |
CN112220859A (zh) | 一种复方中药制剂制备工艺 | |
CN103536670A (zh) | 一种改善营养性贫血的组合物及其制备方法 | |
CN117503801B (zh) | 一种促进乳汁分泌的美洲大蠊粉和制作方法 | |
CN109997944A (zh) | 一种鹿胎多肽压片糖果及其制备方法 | |
CN108096455B (zh) | 一种沙参麦冬颗粒的制备方法 | |
CN109419001A (zh) | 免疫灵胶囊及其制备方法 | |
CN102579984A (zh) | 一种心脑康胶囊的制备方法 | |
CN101371876B (zh) | 一种复方异常黑胆质成熟剂的总多糖的提取制备方法 | |
CN105935132A (zh) | 一种健胃消食当归陈皮咀嚼片及其制备方法 | |
CN105920298A (zh) | 一种川贝化痰止咳当归陈皮咀嚼片及其制备方法 | |
CN102475761B (zh) | 一种治疗慢性肾衰的肾康口服固体复方制剂及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB02 | Change of applicant information | ||
CB02 | Change of applicant information |
Address after: 511500 construction of No. two road, hi tech Industrial Development Zone, Qingyuan, Guangdong, 31 Applicant after: GUANGDONG RONGDA BIOLOGY Co.,Ltd. Address before: 510515 bio tech city, Qingyuan high tech Industrial Development Zone, Qingyuan, Guangdong Applicant before: GUANGDONG RONGDA BIOENGINEERING Co.,Ltd. |
|
GR01 | Patent grant | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Preparation of Qingkailing granules for animals Effective date of registration: 20200909 Granted publication date: 20180731 Pledgee: Bank of China Limited Qingyuan Branch Pledgor: GUANGDONG RONGDA BIOLOGY Co.,Ltd. Registration number: Y2020440000253 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Granted publication date: 20180731 Pledgee: Bank of China Limited Qingyuan Branch Pledgor: GUANGDONG RONGDA BIOLOGY Co.,Ltd. Registration number: Y2020440000253 |